Stocks Close Out A Big First Quarter… And The True Cost Of Diabetes Drugs 3/28/24
Publisher |
CNBC
Media Type |
audio
Categories Via RSS |
Business
Investing
News
Publication Date |
Mar 28, 2024
Episode Duration |
00:43:50

Q1 is in the books, and stocks are heading into Q2 with some major accomplishments. Can the market rally keep raging? And where you should be positioned going into the second quarter. Plus… what it really costs to craft these diabetes drugs. A new study pointing to a $5 price tag for a month’s worth of one blockbuster GLP-1 drug. The dollar dichotemy… and if prices will come down for the public.

 

Fast Money Disclaimer

 

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review